[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].

PaperCitations, authors & open-access status

[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients]. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 147 citations, 2005 year and closed oa status.